Importantly, FANCD2 in HCC revealed a similar trend to the aforementioned three checkpoints, which has been successfully validated by IPS analysis, indicating that it might exert a pivotal role in restoring immune cytotoxic activity. Here, FANCD2 is linked to hepatocellular carcinoma.